Shares of Eli Lilly & Co. LLY slipped 6.59% to $744.91 Tuesday, on what proved to be an all-around great trading session for ...
Palantir stock rebounds, sales of Eli Lilly’s blockbuster GLP-1 medicines miss estimates, and Boeing’s 2024 deliveries fall ...
There's still a lot to like about Eli Lilly stock, an analyst said Wednesday after the weight-loss drugs kingpin cut its ...
while Dow Jones Industrial Average futures fell 0.2% and S&P 500 futures were 0.1% lower. All three major indexes rose Tuesday, helped by strong corporate earnings from Palantir, Eli Lilly ...
Wall Street analyzed the cooler-than-expected producer price index for December on Tuesday and looked ahead to the consumer ...
Inflation data this week has come in below forecasts. Earnings season is off to a solid start. Is this the medicine the ...
US stocks gave up early gains to end mixed. Investors await key consumer inflation data and the start of earnings season on ...
Eli Lilly unexpectedly lowered its full-year 2024 guidance. The miss appears to stem from a lack of the typical December ...